PAVmed (PAVM) Net Cash Flow (QoQ) (2015 - 2025)
PAVmed (PAVM) Net Cash Flow (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | PAVmed | 32.44 Mn | 28.66 Mn | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -67.29% |
| Sep 30, 2025 | -171.65% |
| Jun 30, 2025 | -16.63% |
| Mar 31, 2025 | 260.71% |
| Jun 30, 2024 | -100.63% |
| Mar 31, 2024 | 187.12% |
| Dec 31, 2023 | 37.06% |
| Sep 30, 2023 | 11.24% |
| Jun 30, 2023 | -227.07% |
| Mar 31, 2023 | 155.96% |
| Dec 31, 2022 | -103.64% |
| Sep 30, 2022 | -2,111.54% |
| Jun 30, 2022 | 103.32% |
| Mar 31, 2022 | -131.37% |
| Dec 31, 2021 | 780.13% |
| Sep 30, 2021 | -9.99% |
| Jun 30, 2021 | -117.05% |
| Mar 31, 2021 | 249.10% |
| Dec 31, 2020 | 638.91% |
| Sep 30, 2020 | 173.47% |